000 01213 a2200337 4500
005 20250513214239.0
264 0 _c20000830
008 200008s 0 0 eng d
022 _a0004-8461
024 7 _a10.1046/j.1440-1673.1999.00717.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAllen, B J
245 0 0 _aTargeted alpha therapy: evidence for potential efficacy of alpha-immunoconjugates in the management of micrometastatic cancer.
_h[electronic resource]
260 _bAustralasian radiology
_cNov 1999
300 _a480-6 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAlpha Particles
650 0 4 _aAnimals
650 0 4 _aAstatine
_xtherapeutic use
650 0 4 _aBismuth
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aImmunoconjugates
_xtherapeutic use
650 0 4 _aMice
650 0 4 _aNeoplasm Metastasis
650 0 4 _aNeoplasms
_xradiotherapy
650 0 4 _aRadioisotopes
_xtherapeutic use
650 0 4 _aTerbium
_xtherapeutic use
650 0 4 _aTumor Cells, Cultured
773 0 _tAustralasian radiology
_gvol. 43
_gno. 4
_gp. 480-6
856 4 0 _uhttps://doi.org/10.1046/j.1440-1673.1999.00717.x
_zAvailable from publisher's website
999 _c10852253
_d10852253